NSTK · 01.2026Independent supplement reference
NutriStack
Edition 1.0Updated August 1, 2026

Supplement × Supplement·Evidence index

Lycopene and Saw Palmetto: what the published research says

PubMed indexes 8 records that name Lycopene and Saw Palmetto together, either in the title or in an interaction, co-administration, or pharmacokinetic context. Each one is listed below with its study design and, where the abstract states one, the authors’ own conclusion, quoted and linked. This page reports that literature. It does not tell you whether to combine them.

Read this first

An evidence index, not guidance.

Every statement below is attributed to a named, dated, linked source.

This page lists published research relevant to Lycopene and Saw Palmetto. It deliberately does not state whether the combination is safe, whether it interacts, in which direction, at what dose, or how far apart to take them.

The research

8 studies naming Lycopene and Saw Palmetto.

Strongest relevance first: papers naming both substances in the title, then human trials and systematic reviews.

Non-hormonal treatment for male infertility: the potential role of Serenoa repens, selenium and lycopene.

European review for medical and pharmacological sciences · 2019 · PMID 31002161

Systematic ReviewHuman subjects

“By triggering multiple inflammatory and oxidative pathways, the combined administration of SrE, selenium and lycopene might likely improve the sperm quality. Proper studies are needed to test this hypothesis. Finally, since prostatitis can affect the sperm quality and considering the anti-estrogenic properties of SrE, we speculate about a possible specific indication in those patients with male infertility and "metabolic" prostatitis (where obesity and abnormal…”

Cannarella et al. · Authors' conclusion

Names both Lycopene and Saw Palmetto in its title.

Serenoa repens + selenium + lycopene vs tadalafil 5 mg for the treatment of lower urinary tract symptoms secondary to benign prostatic obstruction: a Phase IV, non-inferiority, open-label, clinical study (SPRITE study).

BJU international · 2018 · PMID 29569389

Clinical Trial, Phase IVComparative StudyEquivalence TrialMulticenter Study

“We have shown that treatment with SeR-Se-Ly was not inferior to tadalafil 5 mg for improving IPSS and Qmax in men with LUTS.”

Morgia et al. · Authors' conclusion

Names both Lycopene and Saw Palmetto in its title.

Serenoa repens associated with selenium and lycopene extract and bromelain and methylsulfonylmethane extract are able to improve the efficacy of levofloxacin in chronic bacterial prostatitis patients.

Archivio italiano di urologia, andrologia : organo ufficiale [di] Societa italiana di ecografia urologica e nefrologica · 2016 · PMID 27711089

Clinical Trial, Phase IIIComparative StudyRandomized Controlled Trial

“The combination of serenoa repens, selenium, lycopene + bromelain and methylsulfonylmethane extracts improved the clinical efficacy of levofloxacin in patients affected by CBP without the development of side effects.”

Cai et al. · Authors' conclusion

Names both Lycopene and Saw Palmetto in its title.

Serenoa repens, lycopene and selenium versus tamsulosin for the treatment of LUTS/BPH. An Italian multicenter double-blinded randomized study between single or combination therapy (PROCOMB trial).

The Prostate · 2014 · PMID 25154739

Multicenter StudyRandomized Controlled Trial225 participants

“SeR-Se-Ly + tamsulosin therapy is more effective than single therapies in improving IPSS and increasing Qmax in patients with LUTS.”

Morgia et al. · Authors' conclusion

Names both Lycopene and Saw Palmetto in its title.

Serenoa Repens-Lycopene-Selenium and Epilobium-Palmitoylethanolamide-Calendula after transperineal prostate biopsy: a tertiary single center experience.

World journal of urology · 2026 · PMID 42287322

Human subjects

“Patients with mild pre-biopsy LUTS treated with post-biopsy phytotherapeutic combination showed reduced odds of short-term IPSS increase at 1-week after biopsy compared to untreated patients. These results are hypothesis-generating and prospective randomized trials are needed to confirm these findings.”

Zaurito et al. · Authors' conclusion

Names both Lycopene and Saw Palmetto in its title.

Comparison of Serenoa repens, lycopene, and selenium versus dutasteride for the treatment of LUTS/BPH: an Italian multicenter case-control prospective study (COMP study).

Frontiers in urology · 2025 · PMID 40777606

“SeR-Se-Ly could be a valid alternative to dutasteride, providing comparable effects on symptoms related to LUTS/BPH and avoiding sexual dysfunctions. SeR-Se-Ly should not be substituted for dutasteride in those patients for whom prostate volume reduction is desired.”

Morgia et al. · Authors' conclusion

Names both Lycopene and Saw Palmetto in its title.

Limitations

What this evidence cannot tell you.

Search-based evidence indexes have real limits, and it is worth being explicit about them:

NutriStack

Track what you actually take.

NutriStack is a free iPhone app for organising a supplement routine: what you take, when, and what the published record says about it. Its exploratory interaction checker covers Lycopene, Saw Palmetto, and several hundred other substances.

The checker is a research and organisation tool, not a clinical decision aid, and its per-pair assessments are excluded from search until they pass claim-level review.

NutriStack is an informational and organizational tool, not a medical service, and not a substitute for professional advice. Always consult a qualified healthcare professional before starting, stopping, or changing any supplement or medication.